ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Keytruda scores ground-breaking European approval in lung cancer subgroup
Keytruda (pembrolizumab) has chalked up yet another approval for MSD, this time in Europe in combination with permextred and platinum-based chemotherapy in the first-line...
-
Sanofi wins European approval for rare blood-clotting disorder treatment
September 05, 2018The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in June had recommended the approval of caplacizumab, which is to be prescribed to adults suffering acquired thrombotic thrombocytopenic purpura (aTTP)
Pharma Sources Insight January 2025
